// App-Quantinova.ai

POS08 : The safety and efficacy of full metal jacket with second generation drug-eluting stents for chronic total occlusion

Researchers

Presenter

  • Honda Y

Principal Investigators

  • Muramatsu T

  • Tukahara R

  • Takimura H

  • Mori S

  • Tsutumi M

  • Takama T

  • Takafuji H

  • Tokuda T

  • Makino K

  • Ito Y

  • Ishimori H

  • Hirano K

  • Nakano M

  • Yamawaki M

  • Araki M

  • Kobayashi N

  • Sakamoto Y

Medical Centers

  • Saiseikai Yokohama-city Eastern Hospital, Yokohama, kanagawa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Everolimus

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim